Connor, Clark & Lunn Investment Management (CC&L)’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.9M | Sell |
|
|||||
|
2025
Q1 | $14.4M | Buy |
|
|||||
|
2024
Q4 | $15.1M | Buy |
|
|||||
|
2024
Q3 | $10M | Buy |
|
|||||
|
2024
Q2 | $2.64M | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $845K | Sell |
|
|||||
|
2023
Q2 | $3.2M | Buy |
|
|||||
|
2023
Q1 | $1.51M | Buy |
|
|||||
|
2022
Q4 | $830K | Sell |
|
|||||
|
2022
Q3 | $707K | Buy |
|
|||||
|
2022
Q2 | $644K | Buy |
|
|||||
|
2022
Q1 | $356K | Buy |
|
|||||
|
2021
Q4 | $180K | Buy |
|
|||||
|
2021
Q3 | $150K | Buy |
|
|||||
|
2021
Q2 | $84K | Buy |
|